Back Pain Medications: Mechanisms, Options, and Risks

Pharmacologic management targets pain pathways. Choice depends on acuity, mechanism, comorbidities, and risk profile.

Medication Classes

ClassExamplesMechanismKey Risks
NSAIDsIbuprofen, naproxen, celecoxib, diclofenacCOX inhibition → ↓ prostaglandinsGI bleed, renal, CV (non-selective); celecoxib lower GI risk
AcetaminophenTylenolCentral COX/cannabinoidHepatotoxicity >4g/day; safe in renal disease
Muscle RelaxantsCyclobenzaprine, methocarbamol, tizanidine, baclofenCentral sedation / GABA-B / α2-agonistSedation, dizziness, falls (elderly); short-term only
OpioidsHydrocodone, oxycodone, tramadol, buprenorphineμ-opioid receptor agonismDependence, OIC, respiratory depression, hyperalgesia; avoid chronic LBP
AnticonvulsantsGabapentin, pregabalinα2δ calcium channelDizziness, edema, weight gain; evidence weak for axial LBP
AntidepressantsDuloxetine (SNRI), amitriptyline (TCA)Serotonin/norepinephrine reuptake inhibitionDuloxetine FDA-approved chronic LBP; TCAs anticholinergic
TopicalsDiclofenac gel, lidocaine patch, capsaicinLocal penetrationMinimal systemic; skin irritation
CorticosteroidsOral burst, epidural injectionPotent anti-inflammatoryHyperglycemia, HPA suppression, bone loss (chronic)

Prescribing Principles

  • Stepwise: NSAID/acetaminophen → add muscle relaxant (acute) → consider duloxetine (chronic) → avoid opioids.
  • Shortest duration, lowest effective dose.
  • Screen for substance use, mental health, fall risk.
  • PDMP check; controlled substance agreement if opioids.
  • Non-pharmacologic (PT, CBT, exercise) concurrent, not sequential.

Interventional Options

Epidural steroid injection (radiculopathy), facet injection/RFA (facetogenic), SI joint injection, spinal cord stimulation (refractory).

Medications facilitate participation in active rehab—they are not the rehab.

Back Pain - Related Articles